| |
| Frequently Asked Questions |
 |
|
What is Abraxis BioScience ticker symbol and on what exchange does it trade? |
|
| |
Abraxis BioScience, Inc. trades on Nasdaq under the symbol "ABBI". |
|
|
|
Please describe Abraxis BioScience. |
|
| |
Abraxis BioScience was formed when American BioScience, a drug development company, merged into American Pharmaceutical Partners (APP), a specialty pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products. The combined company brings together the strengths of a development stage biotechnology company with those of a growing and profitable injectable pharmaceutical business to create an integrated global biopharmaceutical company. |
|
|
|
Why did APP and American BioScience merge? |
|
| |
The merger allows us to expand globally and better maximize the strengths of each company to feed the future growth of the company. |
|
|
|
When did Abraxis BioScience go public and at what price? |
|
| |
The predecessor company, American Pharmaceutical Partners, completed its initial public offering in December 2001 at a price of $16.00 per share. |
|
|
|
Does Abraxis BioScience report on a calendar year? |
|
| |
Yes, Abraxis BioScience reports on a calendar year. |
|
|
|
Does the company pay a dividend? |
|
| |
No. Abraxis BioScience intends to retain earnings to finance the growth and expansion of its business and for general corporate purposes. We have never paid cash dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future. |
|
|
|
Who is ABBI's Transfer Agent? |
|
| |
American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
Telephone: (800) 937-5449
|
|
|
|
I've lost my stock certificates, how can I replace them? |
|
| |
Please contact our transfer agent. |
|
|
|
Who should I contact if I change my address or need to transfer certificates? |
|
| |
Please contact our transfer agent. |
|
|
|
Who are the company's auditors? |
|
| |
Auditors for Abraxis BioScience are Ernst & Young, LLP. |
|
|
|
|
